Figure 1
From: A dramatic, objective antiandrogen withdrawal response: case report and review of the literature
Radiographic response to Bicalutamide withdrawal. Panel A depicts computed tomography scan of abdomen and pelvis with significant periaortic and retroperitoneal adenopathy about 2 months after cessation of bicalutamide. Panel B depicts dramatic egression of adenopathy in response to bicalutamide withdrawal after 8 months. Panel C depicts durable response 20 months after bicalutamide withdrawal.